Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat

Overview of attention for article published in Leukemia, January 2026

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

blogs: 1 blog

twitter: 2 X users

Readers on

mendeley: 4 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 150 followers.

RT @le_markg: Finally out! Imetelstat changes the game in LR-MDS by: → Shrinking the MDS clone → Reducing erythroid dysplasia → Restoring…

Finally out! Imetelstat changes the game in LR-MDS by: → Shrinking the MDS clone → Reducing erythroid dysplasia → Restoring normal erythropoiesis A true paradigm shift — treating disease biology. #MDSs #anemia ⁦@Santin13Valeria⁩ https://t.co/Xdm0z06r5O

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.